NTPC price analysisNTPC is currently trading around ₹360, having shown a modest gain of about 4% over the past year. The stock reached its all-time high of ₹448.45 in September 2024 and has since pulled back, with recent price action reflecting some consolidation after a strong multi-year rally . Over the last month, NTPC has delivered a positive return of approximately 2.5%, indicating some short-term strength despite a slight decline of nearly 1.8% in the past week.
Fundamentally, NTPC remains a large-cap, stable utility with a market capitalization near ₹3.5 lakh crore and a price-to-earnings (PE) ratio of about 15.9, which is below the industry average, suggesting reasonable valuation. The company boasts a healthy dividend yield of 2.5%, and its return on equity (ROE) stands at 13.1%. Promoter holding remains steady at 51.1%, and the company continues to report strong profits, with net profit for the latest fiscal year exceeding ₹20,000 crore.
Analyst sentiment is generally positive, with some brokerages forecasting up to 35% further upside from current levels and price targets ranging between ₹305 and ₹500 for 2025.
Technical indicators and historical trends show NTPC often delivers positive returns in April, with an average gain of about 3% for the month
In summary, NTPC is viewed as a fundamentally sound, dividend-paying stock with moderate growth prospects and reasonable valuation. While the stock is off its recent highs, the outlook remains constructive, supported by positive earnings, stable fundamentals, and favorable long-term forecasts from analysts 
Long
## TORNTPHARM Price AnalysisTorrent Pharmaceuticals (TORNTPHARM) is currently trading near ₹3,254, maintaining a strong uptrend over the past several years. The stock has delivered a return of approximately 165% from July 2020 to November 2024, including a stock split, highlighting its consistent long-term growth.
**Valuation and Fair Value**
TORNTPHARM is trading well above its estimated intrinsic value. Independent valuations suggest a fair value in the range of ₹1,560 to ₹1,940 per share, meaning the current market price is overvalued by about 40%. The price-to-earnings (PE) ratio stands at approximately 59–66, which is significantly higher than the sector average of around 49, indicating a premium valuation. The price-to-book (PB) ratio is also elevated at 16, compared to the sector average of 6.29.
**Recent Performance**
The stock has shown positive momentum in the short term, with returns of 3.5% over the past week and 5.7% over the past month. Over the last year, TORNTPHARM has gained nearly 28%, and over three years, the return is more than 128%. Despite some volatility, the stock has outperformed many of its peers and the broader market.
**Fundamental Trends**
Torrent Pharma’s India business, which constitutes the bulk of its revenue, grew by 12% in Q3 FY25, driven by strong performance in branded generics. However, the company faces challenges in international markets, particularly the US, due to regulatory headwinds and pricing pressures. Revenue growth over the past five years has averaged 7% annually, slightly below the industry average, but net income growth has been robust at over 30% per year, outpacing peers.
**Analyst Outlook**
Analysts have a moderately positive outlook, with a one-year price target averaging around ₹3,600, and a range between ₹2,959 and ₹4,200 . About 68% of analysts currently rate the stock as a buy.
**Dividend and Market Cap**
The dividend yield is 0.86%, which is above the sector average, and the company’s market capitalization is approximately ₹1.1 lakh crore, placing it among the larger players in the Indian pharmaceutical sector.
**Summary**
TORNTPHARM has demonstrated strong long-term price appreciation and profitability, but it is currently trading at a significant premium to its estimated intrinsic value. Short-term technicals are mixed, with some bullish undertones, but caution is warranted due to high valuation multiples. The company’s growth is primarily driven by its domestic business, while international operations face ongoing challenges. Analyst sentiment remains positive, but the upside may be limited unless earnings growth accelerates or valuation multiples contract.
Long
Som Distilleries & Breweries Ltd (SDBL) Price Analysis
- **Current Price:** ₹156.00 (all-time high as of April 22, 2025)
- **Day’s Range:** ₹127.66 – ₹143.40
- **Previous Close:** ₹128.38
- **Volume:** 13.36 million (well above 20-day average of 1.34 million)
- **52-Week Range:** ₹95.61 – ₹148.90 (new all-time high today)
- **VWAP:** ₹137.86
- **Market Cap:** ₹2,931 crore
### **Trend & Momentum**
- SDBL has surged sharply, breaking out to a new all-time high with exceptionally high volume, indicating strong bullish momentum
- The stock has rallied over 20% in a single session, moving far above recent resistance levels and its VWAP
- Technical patterns suggest a bullish formation with potential for further upside, possibly another 10% move, according to chartists
### **Support & Resistance**
- **Immediate Support:** ₹143.40 (today’s high), then ₹127.66 (today’s low), and ₹128.38 (previous close)
- **Resistance:** With a new all-time high at ₹156.00, the stock is in price discovery; next resistance will form as the stock trades higher
### **Valuation**
- **TTM PE:** 30.48 (sector PE: 88.54)
- **P/B:** 4.75
- **EPS (TTM):** ₹4.67 (+5.28% YoY)
- **Book Value per Share:** ₹30.02
### **Outlook**
- **Short-Term:** The breakout and volume spike suggest continued bullishness. However, after such a sharp rally, some profit booking or volatility is possible.
- **Medium-Term:** Sustained trade above ₹143–₹148 keeps the trend positive. Watch for consolidation near new highs before the next leg up.
- **Downside Risk:** If the stock falls below ₹143, it may retest support around ₹128–₹130
Long
Piramal Pharma (PPLPHARMA) Stock Price Analysis**Piramal Pharma (PPLPHARMA) Indian Stock Price Analysis – April 22, 2025**
- **Current Price:** ₹220.70 (as of April 21, 2025)
- **Short-Term Trend:** Sideways to weak. The stock has been volatile, trading mostly between ₹217 and ₹225 in recent sessions
- **Recent Performance:**
- 1 week: +1.86%
- 1 month: +6.36%
- 3 months: –4.46%
- 1 year: +55.38%
- **Moving Averages:** The stock is above its 50-day moving average but below the 5-day, 20-day, 100-day, and 200-day moving averages, indicating mixed momentum and some weakness in the short term
- **Support:** ₹217
- **Resistance:** ₹225–₹231
- **Volatility:** High; the stock is 3.27x as volatile as the Nifty
- **Sector Comparison:** Underperforming its sector in the short term, but strong annual gains
- **Analyst View:** Mixed; some analysts suggest buying for the long term, but caution is warranted in the short term due to recent weakness
**Summary:**
PPLPHARMA has shown strong gains over the past year but is currently consolidating with a slight bearish bias. The price is range-bound, with support at ₹217 and resistance around ₹225–₹231. Watch for a breakout above resistance for renewed bullish momentum, or a drop below support for further downside risk 
Long
Short
Kotak Mahindra BankKotak Mahindra Bank - Technical Analysis & Key Insights
📌 Chart Patterns Identified:
🔻 Cypher Pattern (Bearish Reversal Zone) – If the price faces rejection, it may decline towards the 🟥 Handle Retest Range.
🔼 Cup & Handle Pattern (Bullish Breakout Signal) – If the price sustains above 🔵 ₹1,938.85 (Breaking Range), an upward breakout is expected.
📊 Key Levels & Targets:
🔵 Breaking Range: ₹1,938.85 (Confirmation Level for trend direction).
🟥 Handle Retest Range: ₹1,805 - ₹1,858 (Potential pullback zone before resuming trend).
🟢 Bullish Target Levels:
🎯 Target 1: ₹2,071.45
🎯 Target 2: ₹2,286.35
🔻 Bearish Target: ₹1,591.30 (If a downward breakdown occurs).
⚖️ Risk-Reward Ratio & Market Sentiment:
📈 Upside Potential: +22.84% (Bullish breakout possibility).
📉 Downside Risk: -11.67% (If bearish reversal happens).
📊 Market Sentiment: Neutral to Bullish (but needs confirmation).
📌 Trading Strategy:
✅ Bullish Entry: If price stays above ₹1,938.85 with strong volume confirmation. or Handle retest range 1858
❌ Bearish Entry: If price breaks below ₹1,858 and fails to reclaim resistance.
⚠️ Stop-loss & Risk Management: Set SL below the retest range to minimize potential losses.
📌 Additional Factors to Consider:
📢 Volume Confirmation: A strong breakout should be backed by increased trading volume.
📰 Fundamental News: Earnings reports, RBI policies, and global market trends could impact stock movements.
📊 Support & Resistance: Price action near key levels should be closely monitored for validation.
⚠️ Disclaimer:
This analysis is for educational purposes only and not financial advice. 📉📈 Stock market investments are subject to risk; always do your own research before making trading decisions. 🚀 
Long
Long
Short
Short 
Short
Long
Long 
Long
Long
GARTLEY Harmonic Pattern: How does it work?!GARTLEY Harmonic Pattern: How does it work?!
The "Gartley", as its name suggests, was introduced by Henry Mackinley Gartley.
All other harmonic patterns are modifications of the Gartley.
Its construction consists of 5 waves:
XA: This could be any violent movement on the chart and there are no specific requirements for this movement in order to be a Gartley start
AB: This is opposite to the XA movement and it should be about 61.8% of the XA movement.
BC: This price movement should be opposite to the AB movement and it should be 38.2% or 88.6% of the AB movement.
CD: The last price movement is opposite to BC and it should be 127.2% (extension) of CD if BC is 38.2% of BC. If BC is 88.6% of BC, then CD should be 161.8% (extension) of BC.
AD: The overall price movement between A and D should be 78.6% of XA
How to use it
Point D is where you come in, man! It's your entry signal.
-If it's an M pattern, you buy.
-If it's a W, you sell2.
Where to put your STOP LOSS??
-Below or "X" if you are a BUYER.
-Above "X" if you are a SELLER.
These percentages are based on the famous Fibonacci ratios, as mysterious as the pyramids of Egypt!
Ultimately, the Gartley pattern is like a good Cuban cigar: it requires patience and experience to be appreciated at its true value. But once you master it, it can become a powerful tool in your trading arsenal, as effective as a punch from Rocky Balboa! 
Education
Short
Long 
Long
Long
Stock Market Analysis Report: Lupin Limited (NSE: LUPIN)
Introduction
Greetings, traders! If you're looking for a pharmaceutical stock that might just cure your portfolio blues, look no further than Lupin Limited. This stock is brewing up an interesting pattern that’s worth a closer look. Let’s dive into the technical details and see what’s in store!
Price Action Overview
Chart Analysis
Current Price: ₹1,759.30
Daily High: ₹1,767.00
Daily Low: ₹1,598.25
Volume: 10.039M
Key Technical Indicators
Bearish Gartley Pattern: The chart reveals a bearish Gartley pattern, suggesting a potential reversal.
Rectangle Pattern with Potential False Breakout: The price is within a rectangle pattern, hinting at a potential false breakout.
Decreasing Volume: The volume is on a decline, which could signal weakening momentum.
Detailed Analysis
Bearish Gartley Pattern
Formation: The Bearish Gartley pattern, marked by points X, A, B, C, and D, indicates a potential reversal from the current uptrend.
Implications: This pattern suggests that the stock might face resistance at the current levels and could potentially see a pullback.
Rectangle Pattern with Potential False Breakout
Rectangle Pattern: The stock price is trading within a rectangle pattern, showing consolidation between support and resistance levels.
False Breakout: The current breakout might be a false one, as indicated by the rectangle pattern and the resistance at point D.
Decreasing Volume
Volume Trend: The decreasing volume trend suggests that the current upward momentum might be losing steam.
Significance: Lower volume during a breakout can indicate a lack of strong buying interest, increasing the chances of a reversal.
Price Targets and Support Levels
Immediate Resistance: ₹1,800.00 - This is the next resistance level to watch closely.
Support Levels:
Primary Support: ₹1,600.00 - A key level to maintain for bullish sentiment.
Secondary Support: ₹1,400.00 - A more conservative support level aligning with previous consolidation areas.
💊📉
Conclusion
Lupin Limited is showing a bearish Gartley pattern with a potential false breakout within a rectangle pattern. The decreasing volume adds caution to the current bullish momentum. Keep an eye on the resistance level at ₹1,800.00 and monitor the volume to gauge the strength of the current trend. Happy trading, and may your portfolio stay healthy and robust! 🌿💰
Disclaimer
This analysis is based on historical data and chart patterns. Always do your own research and consider your risk tolerance before making any investment decisions.
